Taken together, these findings suggest NSD3 expression influences the proliferation of pancreatic cancer cells, influences global methylation patterns in the genome of cells, and mediates downstream genes relevant to ERBB and EGFR/ERK signaling. This evidence concerns the gene EGFR and familial pancreatic carcinoma.